← 프로그램 목록
ADCPreclinicalActive

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed

GlaxoSmithKline

비교

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed(GlaxoSmithKline)은 HIV Infections 표적 ADC로, HIV Infections; Hepatitis B 영역에서 개발·상용화 중입니다. 작용기전: targeting the Toll-like receptor. 전임상 단계입니다. 대표 임상 효능: ORR 98.1% (ClinicalTrials.gov NCT00289913). 차별점: novel diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed (DTcP), China's first geneti.

출처: ClinicalTrials.gov · PubMed · openFDA최근 동기화됨

개요

임상 2026년 7월 13일 (1일 전)PK/독성 2026년 7월 13일 (1일 전)

HIV Infections

HIV Infections; Hepatitis B

Active

Technology

구조모아 · StructureMoa에서 구조 검색

novel diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed (DTcP), China's first geneti

Mechanism of Action

targeting the Toll-like receptor

임상시험 & 결과

차트 로드 중…

임상 한눈에 보기

  • 58건의 ClinicalTrials.gov 임상 기록
  • Phase·Status 요약은 enrollment 상위 표본 기준입니다
  • 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
  • Phase: Phase 3 · Phase 4
  • Status: Completed · Active, not recruiting · Not yet recruiting
  • 주요 endpoint: Incidence Rate (Per 1000 Person-years) of Pre-specified Maternal Adverse Events for Exposed Cohort women-on or After 1st Day of 27th Week of Pregnancy and Unexposed Historical Cohort-women Groups · Incidence Rate (Per 1000 Persons) of Prespecified Maternal Adverse Events for Exposed Cohort women-on or After 1st Day of 27th Week of Pregnancy and Unexposed Historical Cohort Women Groups · Incidence Rate (Per 1000 Persons) of Pre-specified Infant Adverse Events for Exposed Cohort infants-on or After 1st Day of 27th Week of Pregnancy and Unexposed Historical Cohort Infants Groups · Incidence Rate (Per 1000 Person-years) of Other Maternal Adverse Events for Exposed Cohort women-on or After 1st Day of 27th Week of Pregnancy and Unexposed Historical Cohort Women Groups · Incidence Rate (Per 1000 Persons) of Other Maternal Adverse Events for Exposed Cohort women-on or After 1st Day of 27th Week of Pregnancy and Unexposed Historical Cohort Women Groups
  • 등록된 결과: ORR 98.1%
  • 핵심: This two-stage study evaluates the immunogenicity, safety, and tolerability of the administration of VAQTA™ (Hepatitis A…

임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.

참고문헌

자주 묻는 질문

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed은 어떤 치료제인가요?
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed(GlaxoSmithKline)은 HIV Infections 표적 ADC로, HIV Infections; Hepatitis B 영역에서 개발·상용화 중입니다. 데이터는 바이오모아 (BioMoa)에서 ClinicalTrials.gov·openFDA·PubMed 기반으로 정리합니다.
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed의 임상 단계는?
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed의 현재 단계는 Preclinical입니다.
비슷한 프로그램과 어떻게 비교하나요?
바이오모아 (BioMoa) 비교 페이지에서 PK/PD, 독성, 임상 효능 지표를 나란히 볼 수 있습니다. 동일 타깃·모달리티 프리셋을 함께 참고하세요.